HYEX (Healthy Extracts) EBIT: $-1.08 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HYEX Healthy Extracts Inc HYEX
56 GF Score
Price $1.35
GF Value $1.15
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is Healthy Extracts EBIT?

Healthy Extracts HYEX 56 EBIT is $-1.08 Mil as of Jun. 2026. GuruFocus rates HYEX with a GF Score™ of 56/100 and a GF Value™ of $1.15 (Modestly Overvalued). The stock has 4 warning signs investors should review.

Healthy Extracts's earnings before interest and taxes (EBIT) for the three months ended in Jun. 2026 was $-0.02 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jun. 2026 was $-1.08 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Healthy Extracts's annualized ROC % for the quarter that ended in Jun. 2026 was -0.60%. Healthy Extracts's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2026 was -1.94%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Healthy Extracts's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2026 was -3.76%.

Healthy Extracts  (OTCPK:HYEX) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Healthy Extracts's annualized ROC % for the quarter that ended in Jun. 2026 is calculated as:

ROC % (Q: Jun. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Mar. 2026 ) + Invested Capital (Q: Jun. 2026 ))/ count )
=-0.196 * ( 1 - 0% )/( (27.106 + 38.264)/ 2 )
=-0.196/32.685
=-0.60 %

where

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=27.319 - 0.71 - ( 0.164 - max(0, 1.585 - 1.088+0.164))
=27.106

Invested Capital(Q: Jun. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=32.609 - 1.055 - ( 0.19 - max(0, 8.389 - 1.679+0.19))
=38.264

Note: The Operating Income data used here is four times the quarterly (Jun. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Healthy Extracts's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Jun. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Mar. 2026  Q: Jun. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-0.092/( ( (4.546 + max(0.214, 0)) + (4.308 + max(0.434, 0)) )/ 2 )
=-0.092/( ( 4.76 + 4.742 )/ 2 )
=-0.092/4.751
=-1.94 %

where Working Capital is:

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.254 + 0.521 + 0.149) - (0.71 + 0 + 0)
=0.214

Working Capital(Q: Jun. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.607 + 0.644 + 0.238) - (1.055 + 0 + 0)
=0.434

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Jun. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Healthy Extracts's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Jun. 2026 )
=-1.081/28.781
=-3.76 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Healthy Extracts EBIT Related Terms

Healthy Extracts EBIT Historical Data

* Premium members only.

The historical data trend for Healthy Extracts's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Healthy Extracts EBIT Chart

Healthy Extracts Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.89 -0.91 -2.24 -0.18 -0.94

Healthy Extracts Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.10 -0.46 -0.27 -0.33 -0.02

HYEX vs CABR, BFRI, IGPK: EBIT Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Healthy Extracts's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Healthy Extracts EV-to-EBIT vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Healthy Extracts's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Healthy Extracts's EV-to-EBIT falls into.


HYEX
56GF Score
Healthy Extracts Inc HYEX
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Healthy Extracts EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.08 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of $-1.08 Mil mean?
Healthy Extracts (HYEX) has a EBIT of $-1.08 Mil as of Jun. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Healthy Extracts.
Is Healthy Extracts' EBIT too high?
Healthy Extracts' current EBIT is $-1.08 Mil. Overall, Healthy Extracts has a GF Score™ of 56/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Healthy Extracts' EBIT compare to CABR and BFRI?
Healthy Extracts' EBIT of $-1.08 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Drug Manufacturers company?
A good EBIT depends on the Drug Manufacturers industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Healthy Extracts. Healthy Extracts's current EBIT is $-1.08 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Healthy Extracts stock overvalued right now?
Based on GuruFocus' analysis, Healthy Extracts (HYEX) is currently considered Modestly Overvalued. The stock's GF Value™ is $1.15, compared to a current price of $1.35 — trading 17.4% above its estimated fair value. The current EBIT is $-1.08 Mil. Healthy Extracts' overall GF Score™ is 56/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Healthy Extracts (HYEX), the current EBIT is $-1.08 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Healthy Extracts (HYEX) Overvalued in 2026?

Based on GuruFocus' analysis, Healthy Extracts stock appears to be overvalued. The current stock price of $1.35 is trading 17.4% above its estimated GF Value™ of $1.15. GuruFocus considers Healthy Extracts to be Modestly Overvalued.

Key valuation signals for HYEX:

  • EBIT: $-1.08 Mil
  • GF Value™: $1.15 vs. price of $1.35 (17.4% above fair value)
  • GF Score™: 56/100 with 4 warning signs

No single metric tells the full story. See the HYEX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Healthy Extracts Business Description

Address 7375 Commercial Way, Suite 125, Henderson, NV, USA, 89011
Healthy Extracts Inc through its subsidiaries is engaged in proprietary research and development of natural plant-based formulations, manufacturing, sales, and distribution of cardiovascular and neuro products that provide natural brain solutions. The company also provides superfruit supplements to support overall cholesterol, metabolic and cardiovascular health. Its products are distributed in the United States and Mexico. Its operating segment includes, Health Supplements and Corporate. The company generates maximum revenue from the Health Supplements segment.
56GF Score

Get the complete analysis for HYEX

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.35
Price
$1.15
GF Value